Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
KEGG_2021_Human,Collecting duct acid secretion,4/27,0.0266025347161498,0.9999662504619572,0,0,3.9078322178511216,14.172725719366412,ATP6V1E2;SLC12A7;ATP6V0D2;ATP6V1C2
KEGG_2021_Human,Other types of O-glycan biosynthesis,5/47,0.0493238518718401,0.9999662504619572,0,0,2.675490196078431,8.05147974393134,GALNT7;C1GALT1C1;GALNT15;RFNG;GALNT8
KEGG_2021_Human,Nicotinate and nicotinamide metabolism,4/35,0.060870690485678,0.9999662504619572,0,0,2.8981463932375573,8.111921877689724,BST1;PNP;ENPP1;SIRT1
KEGG_2021_Human,Histidine metabolism,3/22,0.0655246419187217,0.9999662504619572,0,0,3.544477390659748,9.659867003439176,UROC1;AMDHD1;ALDH7A1
KEGG_2021_Human,Mucin type O-glycan biosynthesis,4/36,0.0662638521259312,0.9999662504619572,0,0,2.8074324324324325,7.619682537123082,GALNT7;C1GALT1C1;GALNT15;GALNT8
KEGG_2021_Human,Transcriptional misregulation in cancer,13/192,0.0689881140945785,0.9999662504619572,0,0,1.6358895420586792,4.37407589094087,NTRK1;FLT1;CDKN2C;PBX3;TMPRSS2;MITF;IGF1;FLI1;ETV5;RUNX1;CCNA2;SP1;NUPR1
KEGG_2021_Human,Central carbon metabolism in cancer,6/70,0.0783923968027063,0.9999662504619572,0,0,2.1070008833922262,5.364483952853259,LDHC;NTRK1;IDH1;HIF1A;HK2;FGFR1
KEGG_2021_Human,ECM-receptor interaction,7/88,0.0824375703481929,0.9999662504619572,0,0,1.9428138830654555,4.8487077979442335,TNXB;SV2C;COL4A2;LAMA4;COL9A1;ITGB8;CD44
KEGG_2021_Human,HIF-1 signaling pathway,8/109,0.0951485315607457,0.9999662504619572,0,0,1.7809157539130536,4.189276833169074,LDHC;EGLN3;FLT1;CAMK2A;IGF1;TEK;HIF1A;HK2
KEGG_2021_Human,Rheumatoid arthritis,7/93,0.1030900540703512,0.9999662504619572,0,0,1.8293796621325145,4.1566293191702055,IL11;FLT1;CXCL12;TEK;ATP6V1E2;ATP6V0D2;ATP6V1C2
KEGG_2021_Human,Ascorbate and aldarate metabolism,3/30,0.1350831917658595,0.9999662504619572,0,0,2.4932185706833594,4.991085635286804,UGDH;UGT2B15;ALDH7A1
KEGG_2021_Human,Complement and coagulation cascades,6/85,0.1559172373743454,0.9999662504619572,0,0,1.7055955629109452,3.1697298633372677,C3;C5;C6;CFH;F2;F5
KEGG_2021_Human,PI3K-Akt signaling pathway,19/354,0.1836023849032073,0.9999662504619572,0,0,1.2761194029850746,2.163000453112834,CHRM2;NTRK1;TNXB;CSF3R;FLT1;SYK;IRS1;LAMA4;VEGFC;IGF1;GNG12;FGF2;PIK3R6;COL4A2;COL9A1;ITGB8;TEK;FGF10;FGFR1
KEGG_2021_Human,Glycosaminoglycan degradation,2/19,0.1940107498163993,0.9999662504619572,0,0,2.6381628853182537,4.326169537195924,HGSNAT;HPSE2
KEGG_2021_Human,Melanoma,5/72,0.1941697337405619,0.9999662504619572,0,0,1.6749780509218613,2.745326856927932,MITF;IGF1;FGF2;FGF10;FGFR1
KEGG_2021_Human,Ras signaling pathway,13/232,0.1952819455990721,0.9999662504619572,0,0,1.334276944435406,2.179289063384706,NTRK1;FLT1;KSR1;PLA2G2C;VEGFC;IGF1;GNG12;FGF2;RRAS;PAK6;TEK;FGF10;FGFR1
KEGG_2021_Human,"Neomycin, kanamycin and gentamicin biosynthesis",1/5,0.1962566491950823,0.9999662504619572,0,0,5.6033372365339575,9.124093562389383,HK2
KEGG_2021_Human,Neuroactive ligand-receptor interaction,18/341,0.2104649614605965,0.9999662504619572,0,0,1.2531708778587836,1.952986727482953,CHRM2;PTGFR;P2RY10;F2;ADRA1A;LTB4R;C3;GRM3;GABRR2;C5;CALCR;HRH2;CHRNE;GNRH1;DRD4;INSL5;PTGDR;DRD5
KEGG_2021_Human,Metabolism of xenobiotics by cytochrome P450,5/76,0.2248681461041067,0.9999662504619572,0,0,1.580281690140845,2.3581612336675493,GSTM2;AKR7A3;UGT2B15;CYP1A2;SULT2A1
KEGG_2021_Human,Calcium signaling pathway,13/240,0.2287871523987243,0.9999662504619572,0,0,1.2867098475415153,1.8978496396616276,CHRM2;NTRK1;PTGFR;FLT1;CAMK2A;VEGFC;FGF2;ADRA1A;HRH2;CAMK1G;DRD5;FGF10;FGFR1
KEGG_2021_Human,Caffeine metabolism,1/6,0.230625222487068,0.9999662504619572,0,0,4.482435597189696,6.575559548462971,CYP1A2
KEGG_2021_Human,Protein digestion and absorption,6/103,0.2780973363149105,0.9999662504619572,0,0,1.3877818658700958,1.7760611605796912,ACE2;CPA1;COL4A2;COL24A1;COL23A1;COL9A1
KEGG_2021_Human,Rap1 signaling pathway,11/210,0.2879770860302401,0.9999662504619572,0,0,1.2408368858510563,1.5446860296059075,FLT1;RRAS;VEGFC;ARAP3;IGF1;TEK;FGF2;RAPGEF3;SIPA1;FGF10;FGFR1
KEGG_2021_Human,Riboflavin metabolism,1/8,0.2950210673181423,0.9999662504619572,0,0,3.201405152224824,3.9079825150537086,ENPP1
KEGG_2021_Human,Cell adhesion molecules,8/148,0.2995762949957761,0.9999662504619572,0,0,1.282172373081464,1.545512823818144,SELP;CDH4;CLDN4;NEGR1;ICAM3;ITGB8;SELE;CD99
KEGG_2021_Human,Lysosome,7/128,0.3074214360230284,0.9999662504619572,0,0,1.2978325276781535,1.5308398210644192,HGSNAT;LAPTM4A;CTSO;M6PR;CTSF;ATP6V0D2;AP1M2
KEGG_2021_Human,Adrenergic signaling in cardiomyocytes,8/150,0.3122307931741118,0.9999662504619572,0,0,1.2639805776809618,1.4712893728259848,ACTC1;CAMK2A;SCN7A;SCN5A;ADRA1A;PIK3R6;RAPGEF3;MYH7
KEGG_2021_Human,Purine metabolism,7/129,0.3142939339926484,0.9999662504619572,0,0,1.2871268945252088,1.4897549508889965,GUCY2C;PNP;ENTPD2;ENPP1;AK3;ADSS1;AK8
KEGG_2021_Human,Phagosome,8/152,0.3249916361454436,0.9999662504619572,0,0,1.2462941099304736,1.400779533144706,C3;TUBA1C;SFTPA2;M6PR;ATP6V1E2;ATP6V0D2;FCAR;ATP6V1C2
KEGG_2021_Human,Regulation of actin cytoskeleton,11/218,0.3301455817139893,0.9999662504619572,0,0,1.1923781395242348,1.3214191679668996,CHRM2;CXCL12;RRAS;INSRR;PAK6;ITGB8;GNG12;F2;FGF2;FGF10;FGFR1
KEGG_2021_Human,Mitophagy,4/68,0.3313920596922978,0.9999662504619572,0,0,1.4013660399529966,1.5477431149415488,RRAS;SP1;MITF;HIF1A
KEGG_2021_Human,Linoleic acid metabolism,2/29,0.3535934378095475,0.9999662504619572,0,0,1.660197125613304,1.7259533942594805,PLA2G2C;CYP1A2
KEGG_2021_Human,Leukocyte transendothelial migration,6/114,0.3612483181577278,0.9999662504619572,0,0,1.2457139117916505,1.2683730681349528,CLDN4;CXCL12;CTNNA1;CD99;RAPGEF3;SIPA1
KEGG_2021_Human,Cysteine and methionine metabolism,3/50,0.3612937849500612,0.9999662504619572,0,0,1.4307761462391368,1.456621461749977,LDHC;MAT2A;APIP
KEGG_2021_Human,Vibrio cholerae infection,3/50,0.3612937849500612,0.9999662504619572,0,0,1.4307761462391368,1.456621461749977,ATP6V1E2;ATP6V0D2;ATP6V1C2
KEGG_2021_Human,Ovarian steroidogenesis,3/51,0.3730627102818789,0.9999662504619572,0,0,1.4008949530516432,1.3812946806844943,ACOT1;IGF1;LDLR
KEGG_2021_Human,TGF-beta signaling pathway,5/94,0.3748132932748513,0.9999662504619572,0,0,1.2594844679444812,1.2359664439529396,GREM2;ZFYVE16;SP1;SMAD6;TGFBR1
KEGG_2021_Human,Ubiquinone and other terpenoid-quinone biosynthesis,1/11,0.3816616813382422,0.9999662504619572,0,0,2.240632318501171,2.1582234610625264,HPD
KEGG_2021_Human,Staphylococcus aureus infection,5/95,0.3833682926565421,0.9999662504619572,0,0,1.2454248366013072,1.1940624604896153,C3;SELP;C5;CFH;FCAR
KEGG_2021_Human,Prostate cancer,5/97,0.4004583543105851,0.9999662504619572,0,0,1.218222506393862,1.114850847312194,INSRR;TMPRSS2;IGF1;ETV5;FGFR1
KEGG_2021_Human,AMPK signaling pathway,6/120,0.407358505534705,0.9999662504619572,0,0,1.179778067075817,1.0595134166459212,CCNA2;IRS1;IGF1;ADIPOR2;ADRA1A;SIRT1
KEGG_2021_Human,Gastric acid secretion,4/76,0.4096453357603801,0.9999662504619572,0,0,1.2451364407886147,1.1112388612520196,KCNE2;HRH2;CAMK2A;SLC26A7
KEGG_2021_Human,Pentose and glucuronate interconversions,2/34,0.4299703751297102,0.9999662504619572,0,0,1.4004249706916765,1.1820132466250337,UGDH;UGT2B15
KEGG_2021_Human,Glutathione metabolism,3/57,0.4424778390660088,0.9999662504619572,0,0,1.244848721961398,1.015005949956435,GSTM2;GPX3;IDH1
KEGG_2021_Human,Phospholipase D signaling pathway,7/148,0.447365323891872,0.9999662504619572,0,0,1.1125719255988225,0.8949303148641805,GRM3;PTGFR;RRAS;SYK;F2;PIK3R6;RAPGEF3
KEGG_2021_Human,Starch and sucrose metabolism,2/36,0.45917676792763,0.9999662504619572,0,0,1.3179091097165714,1.0257550548448906,ENPP1;HK2
KEGG_2021_Human,African trypanosomiasis,2/37,0.4734499073057882,0.9999662504619572,0,0,1.280187573270809,0.9572079806052258,LAMA4;SELE
KEGG_2021_Human,"Alanine, aspartate and glutamate metabolism",2/37,0.4734499073057882,0.9999662504619572,0,0,1.280187573270809,0.9572079806052258,ADSS1;ASS1
KEGG_2021_Human,Aldosterone-regulated sodium reabsorption,2/37,0.4734499073057882,0.9999662504619572,0,0,1.280187573270809,0.9572079806052258,IRS1;IGF1
KEGG_2021_Human,Thiamine metabolism,1/15,0.4808662188679181,0.9999662504619572,0,0,1.6001170960187354,1.1715516198466325,AK8
KEGG_2021_Human,Focal adhesion,9/201,0.491766693408357,0.9999662504619572,0,0,1.050144060283688,0.7453406660277543,TNXB;FLT1;COL4A2;LAMA4;COL9A1;PAK6;VEGFC;ITGB8;IGF1
KEGG_2021_Human,Cytokine-cytokine receptor interaction,13/295,0.495577575715609,0.9999662504619572,0,0,1.032744562928522,0.7250190875925849,TNFSF18;IL11;CSF3R;TNFSF14;IL26;IL10RB;TNFRSF18;TNFRSF19;MPL;TGFBR1;IL1RL2;CXCL12;INHA
KEGG_2021_Human,Pathways in cancer,23/531,0.5047818844248775,0.9999662504619572,0,0,1.0141841119018775,0.6933255232167955,NTRK1;GSTM2;EGLN3;CSF3R;LAMA4;CAMK2A;VEGFC;MITF;IGF1;F2;GNG12;HIF1A;FGF2;TGFBR1;RUNX1;CCNA2;CXCL12;TERT;COL4A2;SP1;CTNNA1;FGF10;FGFR1
KEGG_2021_Human,Lysine degradation,3/63,0.5086946667325963,0.9999662504619572,0,0,1.120011737089202,0.7570241218624106,SMYD1;ALDH7A1;AASS
KEGG_2021_Human,"Glycine, serine and threonine metabolism",2/40,0.5148626123183445,0.9999662504619572,0,0,1.178935028074289,0.7826421324689303,SHMT2;ALDH7A1
KEGG_2021_Human,Phenylalanine metabolism,1/17,0.5243362646621414,0.9999662504619572,0,0,1.3999560889929743,0.903842553719571,HPD
KEGG_2021_Human,Primary bile acid biosynthesis,1/17,0.5243362646621414,0.9999662504619572,0,0,1.3999560889929743,0.903842553719571,AMACR
KEGG_2021_Human,Toxoplasmosis,5/112,0.5250874125159886,0.9999662504619572,0,0,1.046619021440352,0.6742220623596321,IL10RB;LAMA4;LDLR;IRGM;PIK3R6
KEGG_2021_Human,Bile secretion,4/90,0.5403131097687519,0.9999662504619572,0,0,1.0416746372256989,0.6412616510578157,ABCC4;UGT2B15;LDLR;SULT2A1
KEGG_2021_Human,Hypertrophic cardiomyopathy,4/90,0.5403131097687519,0.9999662504619572,0,0,1.0416746372256989,0.6412616510578157,ACTC1;ITGB8;IGF1;MYH7
KEGG_2021_Human,Graft-versus-host disease,2/42,0.5412464305252693,0.9999662504619572,0,0,1.1198710433763188,0.6874671019380074,KLRD1;KLRC1
KEGG_2021_Human,Tryptophan metabolism,2/42,0.5412464305252693,0.9999662504619572,0,0,1.1198710433763188,0.6874671019380074,CYP1A2;ALDH7A1
KEGG_2021_Human,Other glycan degradation,1/18,0.5446881380289783,0.9999662504619572,0,0,1.3175368508058962,0.8004588046377616,ENGASE
KEGG_2021_Human,Glycolysis / Gluconeogenesis,3/67,0.5504696168725349,0.9999662504619572,0,0,1.0497909330985915,0.6267078825350083,LDHC;ALDH7A1;HK2
KEGG_2021_Human,Fat digestion and absorption,2/43,0.5540597294043573,0.9999662504619572,0,0,1.092499928516284,0.6451023984766749,NPC1L1;PLA2G2C
KEGG_2021_Human,Retinol metabolism,3/68,0.5605808826671052,0.9999662504619572,0,0,1.0335861321776816,0.5982207824919322,UGT2B15;CYP1A2;LRAT
KEGG_2021_Human,Apoptosis,6/142,0.569890099801569,0.9999662504619572,0,0,0.9877884015797131,0.5554450189028698,NTRK1;TUBA1C;CTSO;PARP2;CTSF;BOK
KEGG_2021_Human,Renal cell carcinoma,3/69,0.570553243511483,0.9999662504619572,0,0,1.0178723858301324,0.5711778538476493,EGLN3;PAK6;HIF1A
KEGG_2021_Human,ABC transporters,2/45,0.5789178649734141,0.9999662504619572,0,0,1.0415769241255215,0.5693203932128635,ABCC4;ABCC12
KEGG_2021_Human,Epithelial cell signaling in Helicobacter pylori infection,3/70,0.5803842681481864,0.9999662504619572,0,0,1.0026277065377338,0.5454945063275053,ATP6V1E2;ATP6V0D2;ATP6V1C2
KEGG_2021_Human,One carbon pool by folate,1/20,0.5828195916937998,0.9999662504619572,0,0,1.178725502280291,0.6363674819459096,SHMT2
KEGG_2021_Human,Adherens junction,3/71,0.5900718067519692,0.9999662504619572,0,0,0.9878314001657,0.5210919723367126,CTNNA1;TGFBR1;FGFR1
KEGG_2021_Human,Type II diabetes mellitus,2/46,0.5909601356830124,0.9999662504619572,0,0,1.0178514334434616,0.5353966900484726,IRS1;HK2
KEGG_2021_Human,Dilated cardiomyopathy,4/96,0.5916690733946676,0.9999662504619572,0,0,0.9734327900679508,0.510865119095209,ACTC1;ITGB8;IGF1;MYH7
KEGG_2021_Human,Pantothenate and CoA biosynthesis,1/21,0.6006718536437814,0.9999662504619572,0,0,1.1197306791569086,0.5707339988677773,ENPP1
KEGG_2021_Human,Pyruvate metabolism,2/47,0.6027437854233253,0.9999662504619572,0,0,0.9951804090139378,0.5038230914058741,LDHC;ALDH7A1
KEGG_2021_Human,MAPK signaling pathway,12/294,0.6066045335362386,0.9999662504619572,0,0,0.9521718280709724,0.4759699490974528,DUSP4;NTRK1;FLT1;RRAS;VEGFC;IGF1;TEK;GNG12;FGF2;TGFBR1;FGF10;FGFR1
KEGG_2021_Human,Inflammatory mediator regulation of TRP channels,4/98,0.6080169037777013,0.9999662504619572,0,0,0.9526214466084956,0.473979272942734,NTRK1;CAMK2A;IGF1;ASIC1
KEGG_2021_Human,Amino sugar and nucleotide sugar metabolism,2/48,0.6142688933861725,0.9999662504619572,0,0,0.9734950812987412,0.4744060660924451,UGDH;HK2
KEGG_2021_Human,Cell cycle,5/124,0.6159733842712664,0.9999662504619572,0,0,0.940484429065744,0.455713163151834,CCNA2;CDKN2C;ESPL1;CDC14A;CDC25A
KEGG_2021_Human,Platelet activation,5/124,0.6159733842712664,0.9999662504619572,0,0,0.940484429065744,0.455713163151834,SYK;F2;PIK3R6;PRKG1;FERMT3
KEGG_2021_Human,Arginine biosynthesis,1/22,0.6177610220236677,0.9999662504619572,0,0,1.0663544106167058,0.5136134322880127,ASS1
KEGG_2021_Human,Terpenoid backbone biosynthesis,1/22,0.6177610220236677,0.9999662504619572,0,0,1.0663544106167058,0.5136134322880127,DHDDS
KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,4/100,0.6239576810051377,0.9999662504619572,0,0,0.9326772424598512,0.4399184228522882,COL4A2;VEGFC;SELE;TGFBR1
KEGG_2021_Human,Progesterone-mediated oocyte maturation,4/100,0.6239576810051377,0.9999662504619572,0,0,0.9326772424598512,0.4399184228522882,CCNA2;STK10;IGF1;CDC25A
KEGG_2021_Human,Glioma,3/75,0.6273533008147747,0.9999662504619572,0,0,0.9327562597809076,0.4348933330451144,CAMK2A;IGF1;CAMK1G
KEGG_2021_Human,Renin-angiotensin system,1/23,0.6341196785085277,0.9999662504619572,0,0,1.017830530125612,0.4636396948393249,ACE2
KEGG_2021_Human,Pertussis,3/76,0.6363001963751233,0.9999662504619572,0,0,0.919930542157052,0.4158866336768138,C3;C5;SFTPA2
KEGG_2021_Human,Arginine and proline metabolism,2/50,0.6365460874056529,0.9999662504619572,0,0,0.9328350918327472,0.4213601707355723,CKMT1A;ALDH7A1
KEGG_2021_Human,Cholesterol metabolism,2/50,0.6365460874056529,0.9999662504619572,0,0,0.9328350918327472,0.4213601707355723,VAPB;LDLR
KEGG_2021_Human,Malaria,2/50,0.6365460874056529,0.9999662504619572,0,0,0.9328350918327472,0.4213601707355723,SELP;SELE
KEGG_2021_Human,Osteoclast differentiation,5/127,0.6370341824325735,0.9999662504619572,0,0,0.9172131147540984,0.4136007105639843,CALCR;SYK;SIRPG;MITF;TGFBR1
KEGG_2021_Human,Longevity regulating pathway,4/102,0.6394817824158555,0.9999662504619572,0,0,0.9135470874601308,0.4084442951745116,IRS1;IGF1;ADIPOR2;SIRT1
KEGG_2021_Human,Pancreatic secretion,4/102,0.6394817824158555,0.9999662504619572,0,0,0.9135470874601308,0.4084442951745116,BST1;CPA1;PLA2G2C;SLC26A3
KEGG_2021_Human,Vitamin digestion and absorption,1/24,0.649779015310574,0.9999662504619572,0,0,0.9735261175033092,0.4197094520138161,LRAT
KEGG_2021_Human,Oocyte meiosis,5/129,0.6506722853947245,0.9999662504619572,0,0,0.902324478178368,0.3877731913939007,SGO1;ESPL1;CAMK2A;IGF1;FBXO43
KEGG_2021_Human,Relaxin signaling pathway,5/129,0.6506722853947245,0.9999662504619572,0,0,0.902324478178368,0.3877731913939007,COL4A2;VEGFC;GNG12;INSL5;TGFBR1
KEGG_2021_Human,Proteoglycans in cancer,8/205,0.6535876509050231,0.9999662504619572,0,0,0.908455642188914,0.3863467705434117,HPSE2;RRAS;CAMK2A;IGF1;HIF1A;FGF2;CD44;FGFR1
KEGG_2021_Human,Synaptic vesicle cycle,3/78,0.6537401141150779,0.9999662504619572,0,0,0.8953051643192488,0.3805453287349322,ATP6V1E2;ATP6V0D2;ATP6V1C2
KEGG_2021_Human,C-type lectin receptor signaling pathway,4/104,0.6545816416660911,0.9999662504619572,0,0,0.8951821386603995,0.379341454260856,RRAS;KSR1;SYK;CBLB
KEGG_2021_Human,FoxO signaling pathway,5/131,0.6639811832977477,0.9999662504619572,0,0,0.8879084967320261,0.363599833140463,IRS1;PRMT1;IGF1;SIRT1;TGFBR1
KEGG_2021_Human,alpha-Linolenic acid metabolism,1/25,0.6647688941394911,0.9999662504619572,0,0,0.9329137392661982,0.3809234443503506,PLA2G2C
KEGG_2021_Human,Axon guidance,7/182,0.6651475294787926,0.9999662504619572,0,0,0.894811320754717,0.3648561073255958,SEMA5A;EPHA7;CXCL12;RRAS;CAMK2A;PAK6;UNC5C
KEGG_2021_Human,Glycosaminoglycan biosynthesis,2/53,0.6680494901041886,0.9999662504619572,0,0,0.8778245178493437,0.3541082843452445,XYLT2;HS3ST5
KEGG_2021_Human,Glucagon signaling pathway,4/107,0.6764241241407947,0.9999662504619572,0,0,0.868971969014181,0.3397115541854495,LDHC;PRMT1;CAMK2A;SIRT1
KEGG_2021_Human,Th17 cell differentiation,4/107,0.6764241241407947,0.9999662504619572,0,0,0.868971969014181,0.3397115541854495,IRF4;HIF1A;TGFBR1;RUNX1
KEGG_2021_Human,Folate biosynthesis,1/26,0.6791179032812196,0.9999662504619572,0,0,0.8955503512880562,0.3465426331693416,SPR
KEGG_2021_Human,Maturity onset diabetes of the young,1/26,0.6791179032812196,0.9999662504619572,0,0,0.8955503512880562,0.3465426331693416,RFX6
KEGG_2021_Human,Regulation of lipolysis in adipocytes,2/55,0.6878003297175193,0.9999662504619572,0,0,0.8446105863876662,0.3161011722013959,IRS1;PRKG1
KEGG_2021_Human,Biosynthesis of unsaturated fatty acids,1/27,0.6928534113546647,0.9999662504619572,0,0,0.8610610700774636,0.3159550193133433,ACOT1
KEGG_2021_Human,Fatty acid elongation,1/27,0.6928534113546647,0.9999662504619572,0,0,0.8610610700774636,0.3159550193133433,ACOT1
KEGG_2021_Human,Pyrimidine metabolism,2/56,0.6973080414656814,0.9999662504619572,0,0,0.8289262298640963,0.2988511261884327,PNP;ENPP1
KEGG_2021_Human,Insulin signaling pathway,5/137,0.701889805216079,0.9999662504619572,0,0,0.8472816399286988,0.2999197889199642,IRS1;TRIP10;CBLB;PPP1R3A;HK2
KEGG_2021_Human,Butanoate metabolism,1/28,0.7060016195073834,0.9999662504619572,0,0,0.8291265504380259,0.288650249721404,ACSM2A
KEGG_2021_Human,Phototransduction,1/28,0.7060016195073834,0.9999662504619572,0,0,0.8291265504380259,0.288650249721404,GUCA1B
KEGG_2021_Human,ErbB signaling pathway,3/85,0.7099994554643481,0.9999662504619572,0,0,0.8185760906904843,0.2803550060055296,CAMK2A;PAK6;CBLB
KEGG_2021_Human,Cholinergic synapse,4/113,0.7171701741370808,0.9999662504619572,0,0,0.8208799146174495,0.2728950628986965,CHRM2;CAMK2A;GNG12;PIK3R6
KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,7/193,0.7231525097005824,0.9999662504619572,0,0,0.8414041894907689,0.2727286638793011,C3;SYK;ATG14;GNG12;HIF1A;FGF2;PIK3R6
KEGG_2021_Human,Notch signaling pathway,2/59,0.7243971975518745,0.9999662504619572,0,0,0.7851751300878221,0.2531525706188426,KAT2B;RFNG
KEGG_2021_Human,Citrate cycle (TCA cycle),1/30,0.7306353997913434,0.9999662504619572,0,0,0.7718646531535169,0.2422425528955722,IDH1
KEGG_2021_Human,Glyoxylate and dicarboxylate metabolism,1/30,0.7306353997913434,0.9999662504619572,0,0,0.7718646531535169,0.2422425528955722,SHMT2
KEGG_2021_Human,beta-Alanine metabolism,1/30,0.7306353997913434,0.9999662504619572,0,0,0.7718646531535169,0.2422425528955722,ALDH7A1
KEGG_2021_Human,Long-term depression,2/60,0.7329601799317971,0.9999662504619572,0,0,0.7715972025710475,0.2397073987702322,IGF1;PRKG1
KEGG_2021_Human,Mineral absorption,2/60,0.7329601799317971,0.9999662504619572,0,0,0.7715972025710475,0.2397073987702322,SLC26A3;SLC26A6
KEGG_2021_Human,Arachidonic acid metabolism,2/61,0.7412957783293114,0.9999662504619572,0,0,0.7584795437836549,0.2270550779006891,GPX3;PLA2G2C
KEGG_2021_Human,Steroid hormone biosynthesis,2/61,0.7412957783293114,0.9999662504619572,0,0,0.7584795437836549,0.2270550779006891,UGT2B15;CYP1A2
KEGG_2021_Human,Galactose metabolism,1/31,0.7421679740691578,0.9999662504619572,0,0,0.7460967993754879,0.2224709058476028,HK2
KEGG_2021_Human,Breast cancer,5/147,0.7582436316614947,0.9999662504619572,0,0,0.7871996685998343,0.2178579264302528,SP1;IGF1;FGF2;FGF10;FGFR1
KEGG_2021_Human,Base excision repair,1/33,0.7637745728669058,0.9999662504619572,0,0,0.6993925644028103,0.1884741232121351,PARP2
KEGG_2021_Human,Fructose and mannose metabolism,1/33,0.7637745728669058,0.9999662504619572,0,0,0.6993925644028103,0.1884741232121351,HK2
KEGG_2021_Human,SNARE interactions in vesicular transport,1/33,0.7637745728669058,0.9999662504619572,0,0,0.6993925644028103,0.1884741232121351,STX16
KEGG_2021_Human,Salivary secretion,3/93,0.7653738949169282,0.9999662504619572,0,0,0.7455007824726134,0.1993400603400982,BST1;ADRA1A;PRKG1
KEGG_2021_Human,Gastric cancer,5/149,0.7684955974762537,0.9999662504619572,0,0,0.7761846405228758,0.2043852847452102,TERT;CTNNA1;FGF2;TGFBR1;FGF10
KEGG_2021_Human,Cortisol synthesis and secretion,2/65,0.772440969097581,0.9999662504619572,0,0,0.7101732447570666,0.1833665106040857,SP1;LDLR
KEGG_2021_Human,Propanoate metabolism,1/34,0.7738898361941816,0.9999662504619572,0,0,0.6781633666879568,0.1738307308902881,LDHC
KEGG_2021_Human,Aminoacyl-tRNA biosynthesis,2/66,0.7796977957163,0.9999662504619572,0,0,0.6990401524032825,0.1739553560385193,NARS1;TARS3
KEGG_2021_Human,Coronavirus disease,8/232,0.7797371981797234,0.9999662504619572,0,0,0.7978158205430933,0.1984952529586075,C3;SELP;ACE2;C5;C6;SYK;TMPRSS2;F2
KEGG_2021_Human,Tuberculosis,6/180,0.7864453621827711,0.9999662504619572,0,0,0.7705210998740912,0.1851038467997358,C3;KSR1;SYK;IL10RB;CAMK2A;ATP6V0D2
KEGG_2021_Human,Acute myeloid leukemia,2/67,0.7867509596265755,0.9999662504619572,0,0,0.6882496167373072,0.1650722129904099,CCNA2;RUNX1
KEGG_2021_Human,Long-term potentiation,2/67,0.7867509596265755,0.9999662504619572,0,0,0.6882496167373072,0.1650722129904099,CAMK2A;RAPGEF3
KEGG_2021_Human,Circadian entrainment,3/97,0.7896660396304468,0.9999662504619572,0,0,0.7136275097392868,0.1685196807147976,CAMK2A;GNG12;PRKG1
KEGG_2021_Human,Tyrosine metabolism,1/36,0.7928408737891235,0.9999662504619572,0,0,0.639344262295082,0.1484127360829048,HPD
KEGG_2021_Human,Aldosterone synthesis and secretion,3/98,0.7954023194131941,0.9999662504619572,0,0,0.7060785767234989,0.1616264912865858,CAMK2A;LDLR;CAMK1G
KEGG_2021_Human,Adipocytokine signaling pathway,2/69,0.8002628255127636,0.9999662504619572,0,0,0.6676348620321604,0.1487591107734334,IRS1;ADIPOR2
KEGG_2021_Human,Amphetamine addiction,2/69,0.8002628255127636,0.9999662504619572,0,0,0.6676348620321604,0.1487591107734334,CAMK2A;SIRT1
KEGG_2021_Human,Hematopoietic cell lineage,3/99,0.8010074198871987,0.9999662504619572,0,0,0.6986869131455399,0.1550281937068678,IL11;CSF3R;CD44
KEGG_2021_Human,Thyroid cancer,1/37,0.8017128295709071,0.9999662504619572,0,0,0.621552172781681,0.1373660155644337,NTRK1
KEGG_2021_Human,Cellular senescence,5/156,0.801775144068726,0.9999662504619572,0,0,0.7399298792364628,0.1634705471938027,CCNA2;RRAS;SIRT1;CDC25A;TGFBR1
KEGG_2021_Human,Viral protein interaction with cytokine and cytokine receptor,3/100,0.8064831762636099,0.9999662504619572,0,0,0.691447655002178,0.1487111972597089,CXCL12;TNFSF14;IL10RB
KEGG_2021_Human,Dopaminergic synapse,4/132,0.8209893426903383,0.9999662504619572,0,0,0.6983328437132785,0.1377427668592102,CAMK2A;GNG12;DRD4;DRD5
KEGG_2021_Human,cAMP signaling pathway,7/216,0.8210852950334733,0.9999662504619572,0,0,0.747901056242665,0.1474324512876584,CHRM2;ABCC4;RRAS;CAMK2A;ARAP3;RAPGEF3;DRD5
KEGG_2021_Human,Inositol phosphate metabolism,2/73,0.825025005292014,0.9999662504619572,0,0,0.6298895365156943,0.1211539509854967,PLCH1;SYNJ2
KEGG_2021_Human,p53 signaling pathway,2/73,0.825025005292014,0.9999662504619572,0,0,0.6298895365156943,0.1211539509854967,CCNG1;IGF1
KEGG_2021_Human,Oxidative phosphorylation,4/133,0.8254554846127393,0.9999662504619572,0,0,0.6928829739749861,0.1329087721849178,NDUFC2-KCTD14;ATP6V1E2;ATP6V0D2;ATP6V1C2
KEGG_2021_Human,Vascular smooth muscle contraction,4/133,0.8254554846127393,0.9999662504619572,0,0,0.6928829739749861,0.1329087721849178,PLA2G2C;ADRA1A;ACTG2;PRKG1
KEGG_2021_Human,Nicotine addiction,1/40,0.8261156634622295,0.9999662504619572,0,0,0.5736503933225244,0.1095789774196608,GABRR2
KEGG_2021_Human,NF-kappa B signaling pathway,3/104,0.8271305941064079,0.9999662504619572,0,0,0.6639241388927625,0.1260079438668744,CXCL12;TNFSF14;SYK
KEGG_2021_Human,Ferroptosis,1/41,0.8335640457423312,0.9999662504619572,0,0,0.5592798594847775,0.1018139567304083,SLC7A11
KEGG_2021_Human,Thyroid hormone synthesis,2/75,0.8363415881928139,0.9999662504619572,0,0,0.6125680515184121,0.1094770295500132,GPX3;ALB
KEGG_2021_Human,Chronic myeloid leukemia,2/76,0.8417481011014065,0.9999662504619572,0,0,0.6042584202021483,0.104098303214848,TGFBR1;RUNX1
KEGG_2021_Human,Human papillomavirus infection,11/331,0.841961782123598,0.9999662504619572,0,0,0.7667172689573459,0.1318912069376088,CCNA2;TNXB;TERT;COL4A2;LAMA4;COL9A1;ITGB8;RFNG;ATP6V1E2;ATP6V0D2;ATP6V1C2
KEGG_2021_Human,Apelin signaling pathway,4/137,0.8424053240873431,0.9999662504619572,0,0,0.6719030243057703,0.1152273359338159,RRAS;GNG12;PIK3R6;TGFBR1
KEGG_2021_Human,Autophagy,4/137,0.8424053240873431,0.9999662504619572,0,0,0.6719030243057703,0.1152273359338159,RRAS;IRS1;ATG14;HIF1A
KEGG_2021_Human,Drug metabolism,3/108,0.8458626710969239,0.9999662504619572,0,0,0.6384976525821596,0.1068833959675982,GSTM2;UGT2B15;CYP1A2
KEGG_2021_Human,Ribosome biogenesis in eukaryotes,3/108,0.8458626710969239,0.9999662504619572,0,0,0.6384976525821596,0.1068833959675982,NXF1;RIOK2;REXO2
KEGG_2021_Human,cGMP-PKG signaling pathway,5/167,0.8462957936020161,0.9999662504619572,0,0,0.6892883079157589,0.1150328047446605,IRS1;ADRA1A;PIK3R6;PRKG1;MYH7
KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,2/77,0.8469921467396202,0.9999662504619572,0,0,0.5961703790543181,0.0990023521141414,CTNNA1;ITGB8
KEGG_2021_Human,Fatty acid degradation,1/43,0.8475183311951021,0.9999662504619572,0,0,0.532591725214676,0.0881134717262069,ALDH7A1
KEGG_2021_Human,Porphyrin and chlorophyll metabolism,1/43,0.8475183311951021,0.9999662504619572,0,0,0.532591725214676,0.0881134717262069,UGT2B15
KEGG_2021_Human,Antigen processing and presentation,2/78,0.8520777153580832,0.9999662504619572,0,0,0.5882951810945888,0.0941728460327527,KLRD1;KLRC1
KEGG_2021_Human,Serotonergic synapse,3/113,0.8667790523457889,0.9999662504619572,0,0,0.609314980793854,0.0871144795195252,HTR3B;GNG12;RAPGEF3
KEGG_2021_Human,Peroxisome,2/82,0.870913416367596,0.9999662504619572,0,0,0.5587631887456037,0.0772281769262784,AMACR;IDH1
KEGG_2021_Human,Carbohydrate digestion and absorption,1/47,0.8720185387932158,0.9999662504619572,0,0,0.4861775786579778,0.0665793917120163,HK2
KEGG_2021_Human,Intestinal immune network for IgA production,1/48,0.8775025580709321,0.9999662504619572,0,0,0.4758084608102048,0.0621764649678646,CXCL12
KEGG_2021_Human,"Valine, leucine and isoleucine degradation",1/48,0.8775025580709321,0.9999662504619572,0,0,0.4758084608102048,0.0621764649678646,ALDH7A1
KEGG_2021_Human,Cocaine addiction,1/49,0.8827518455687934,0.9999662504619572,0,0,0.4658713895394223,0.0580993583590699,GRM3
KEGG_2021_Human,Ether lipid metabolism,1/49,0.8827518455687934,0.9999662504619572,0,0,0.4658713895394223,0.0580993583590699,PLA2G2C
KEGG_2021_Human,Taste transduction,2/86,0.887519978861634,0.9999662504619572,0,0,0.5320437670965221,0.063485721609852,ENTPD2;HTR3B
KEGG_2021_Human,Neurotrophin signaling pathway,3/119,0.8885450793750705,0.9999662504619572,0,0,0.5776165614375911,0.0682568890971094,NTRK1;IRS1;CAMK2A
KEGG_2021_Human,Chemical carcinogenesis,7/239,0.8896646199055359,0.9999662504619572,0,0,0.6729373373454782,0.0786735878444269,GSTM2;CYP1A2;UGT2B15;FGF2;CDC25A;SULT2A1;FGF10
KEGG_2021_Human,Cardiac muscle contraction,2/87,0.8913505764895607,0.9999662504619572,0,0,0.5257568443555617,0.0604712193518726,ACTC1;MYH7
KEGG_2021_Human,Gap junction,2/88,0.8950597187528663,0.9999662504619572,0,0,0.519616129120205,0.0576071580133411,TUBA1C;PRKG1
KEGG_2021_Human,Thyroid hormone signaling pathway,3/121,0.8950607503045276,0.9999662504619572,0,0,0.5677667701121986,0.0629447166820064,KAT2B;HIF1A;MYH7
KEGG_2021_Human,GABAergic synapse,2/89,0.8986507738847921,0.9999662504619572,0,0,0.5136165797523278,0.0548854686520818,GABRR2;GNG12
KEGG_2021_Human,mTOR signaling pathway,4/154,0.8997358304957952,0.9999662504619572,0,0,0.5952213082647865,0.062887559968178,IRS1;IGF1;ATP6V1E2;ATP6V1C2
KEGG_2021_Human,Cushing syndrome,4/155,0.9024502942591228,0.9999662504619572,0,0,0.5912483171337188,0.0606867122341201,CDKN2C;SP1;CAMK2A;LDLR
KEGG_2021_Human,Morphine addiction,2/91,0.9054917677473968,0.9999662504619572,0,0,0.5020219450189022,0.0498392793682847,GABRR2;GNG12
KEGG_2021_Human,Fanconi anemia pathway,1/54,0.9058139405503134,0.9999662504619572,0,0,0.4218107905085944,0.0417260960728139,SLX4
KEGG_2021_Human,Small cell lung cancer,2/92,0.9087481129954996,0.9999662504619572,0,0,0.4964178715644132,0.0475008990164862,COL4A2;LAMA4
KEGG_2021_Human,Human T-cell leukemia virus 1 infection,6/219,0.9106426668463794,0.9999662504619572,0,0,0.6281457887489839,0.0587973990095314,CCNA2;KAT2B;CDKN2C;TERT;ESPL1;TGFBR1
KEGG_2021_Human,GnRH signaling pathway,2/93,0.9118991835766072,0.9999662504619572,0,0,0.4909369645594733,0.0452770736205972,CAMK2A;GNRH1
KEGG_2021_Human,Legionellosis,1/57,0.9174145517027864,0.9999662504619572,0,0,0.3991510538641686,0.0344051583987188,C3
KEGG_2021_Human,Endocytosis,7/252,0.9175729356378312,0.9999662504619572,0,0,0.6367924528301887,0.0547789298325845,EHD1;ZFYVE16;ARAP3;CBLB;LDLR;EPN1;TGFBR1
KEGG_2021_Human,JAK-STAT signaling pathway,4/162,0.91969620177658,0.9999662504619572,0,0,0.5648455279715598,0.0472842804530745,IL11;CSF3R;IL10RB;MPL
KEGG_2021_Human,Endometrial cancer,1/58,0.9209550868450104,0.9999662504619572,0,0,0.3921278606351945,0.0322893803035181,CTNNA1
KEGG_2021_Human,Hippo signaling pathway,4/163,0.9219235287342183,0.9999662504619572,0,0,0.5612634784086794,0.0456267916700075,MOB1A;FRMD6;CTNNA1;TGFBR1
KEGG_2021_Human,Natural killer cell mediated cytotoxicity,3/131,0.922769541017752,0.9999662504619572,0,0,0.5231349031690141,0.0420473656131661,SYK;KLRD1;KLRC1
KEGG_2021_Human,Choline metabolism in cancer,2/98,0.9261793525714516,0.9999662504619572,0,0,0.4652452129738179,0.0356784354207727,SP1;HIF1A
KEGG_2021_Human,mRNA surveillance pathway,2/98,0.9261793525714516,0.9999662504619572,0,0,0.4652452129738179,0.0356784354207727,NXF1;CPSF4L
KEGG_2021_Human,Viral myocarditis,1/60,0.9275877791027868,0.9999662504619572,0,0,0.378795697217481,0.0284732575568768,MYH7
KEGG_2021_Human,Wnt signaling pathway,4/166,0.9282765709490862,0.9999662504619572,0,0,0.5507826667246957,0.040992309267291,CAMK2A;PRICKLE3;CXXC4;LGR5
KEGG_2021_Human,Glycerolipid metabolism,1/61,0.93069263063972,0.9999662504619572,0,0,0.3724629195940671,0.0267525983548468,ALDH7A1
KEGG_2021_Human,Systemic lupus erythematosus,3/135,0.9318439573747412,0.9999662504619572,0,0,0.5071756295347845,0.035801480026338,C3;C5;C6
KEGG_2021_Human,Melanogenesis,2/101,0.9336682438474596,0.9999662504619572,0,0,0.4510758227053655,0.0309591845477745,CAMK2A;MITF
KEGG_2021_Human,Tight junction,4/169,0.9341597263961366,0.9999662504619572,0,0,0.5406829754655842,0.0368247507204129,TUBA1C;CLDN4;CGNL1;RUNX1
KEGG_2021_Human,Amoebiasis,2/102,0.9360005144959128,0.9999662504619572,0,0,0.4465416178194607,0.0295339289598889,COL4A2;LAMA4
KEGG_2021_Human,Chagas disease,2/102,0.9360005144959128,0.9999662504619572,0,0,0.4465416178194607,0.0295339289598889,C3;TGFBR1
KEGG_2021_Human,Protein processing in endoplasmic reticulum,4/171,0.9378353013676,0.9999662504619572,0,0,0.5341514386034042,0.0342823362446105,ERLEC1;DERL3;UBXN8;UBE2J1
KEGG_2021_Human,Diabetic cardiomyopathy,5/203,0.9381175521276212,0.9999662504619572,0,0,0.5628936423054071,0.0359576547250077,IRS1;SP1;CAMK2A;NDUFC2-KCTD14;TGFBR1
KEGG_2021_Human,Viral carcinogenesis,5/203,0.9381175521276212,0.9999662504619572,0,0,0.5628936423054071,0.0359576547250077,C3;CCNA2;KAT2B;SYK;ATP6V0D2
KEGG_2021_Human,GnRH secretion,1/64,0.939231798940108,0.9999662504619572,0,0,0.3546708300806661,0.0222353687765802,GNRH1
KEGG_2021_Human,Fluid shear stress and atherosclerosis,3/139,0.9399275795342216,0.9999662504619572,0,0,0.4921551367025683,0.0304902163682678,GSTM2;SELE;ASS1
KEGG_2021_Human,T cell receptor signaling pathway,2/104,0.9404338027487494,0.9999662504619572,0,0,0.4377399259821162,0.0268833676441188,PAK6;CBLB
KEGG_2021_Human,"Parathyroid hormone synthesis, secretion and action",2/106,0.944574355384691,0.9999662504619572,0,0,0.4292767607539002,0.0244777346004357,SP1;FGFR1
KEGG_2021_Human,Signaling pathways regulating pluripotency of stem cells,3/143,0.947115866821851,0.9999662504619572,0,0,0.4779929577464789,0.0259711937628916,IGF1;FGF2;FGFR1
KEGG_2021_Human,Insulin resistance,2/108,0.9484400504676176,0.9999662504619572,0,0,0.4211329602512774,0.0222933875649108,IRS1;PPP1R3A
KEGG_2021_Human,Fc epsilon RI signaling pathway,1/68,0.9490052100699852,0.9999662504619572,0,0,0.3334265440945157,0.0174518755182393,SYK
KEGG_2021_Human,Retrograde endocannabinoid signaling,3/148,0.9549763235175376,0.9999662504619572,0,0,0.4613890237979601,0.0212556067946192,GABRR2;GNG12;NDUFC2-KCTD14
KEGG_2021_Human,TNF signaling pathway,2/112,0.9554137211849568,0.9999662504619572,0,0,0.4057337738463178,0.018505848670989,VEGFC;SELE
KEGG_2021_Human,Glutamatergic synapse,2/114,0.9585528901056264,0.9999662504619572,0,0,0.3984466588511137,0.016866461409524,GRM3;GNG12
KEGG_2021_Human,Oxytocin signaling pathway,3/154,0.9629650902286828,0.9999662504619572,0,0,0.4429157727823897,0.0167148080966801,CAMK2A;PIK3R6;CAMK1G
KEGG_2021_Human,Neutrophil extracellular trap formation,4/189,0.9634103327675382,0.9999662504619572,0,0,0.4817226156826626,0.0179566245543705,C3;SELP;C5;SYK
KEGG_2021_Human,Pancreatic cancer,1/76,0.9640929386939756,0.9999662504619572,0,0,0.297736143637783,0.0108874901278346,TGFBR1
KEGG_2021_Human,Non-alcoholic fatty liver disease,3/155,0.9641594530506616,0.9999662504619572,0,0,0.4399786879169755,0.0160586018802701,IRS1;NDUFC2-KCTD14;ADIPOR2
KEGG_2021_Human,"Growth hormone synthesis, secretion and action",2/119,0.965500894935608,0.9999662504619572,0,0,0.3813188244606767,0.0133874366950786,IRS1;IGF1
KEGG_2021_Human,Bacterial invasion of epithelial cells,1/77,0.9656337248205042,0.9999662504619572,0,0,0.2938031554295575,0.0102744971668872,CTNNA1
KEGG_2021_Human,Leishmaniasis,1/77,0.9656337248205042,0.9999662504619572,0,0,0.2938031554295575,0.0102744971668872,C3
KEGG_2021_Human,Hepatitis C,3/157,0.9664401816377064,0.9999662504619572,0,0,0.4342189500640205,0.0148224433610909,CLDN4;EIF3E;LDLR
KEGG_2021_Human,B cell receptor signaling pathway,1/81,0.9711640848915144,0.9999662504619572,0,0,0.2790544496487119,0.0081650884076728,SYK
KEGG_2021_Human,Hepatocellular carcinoma,3/168,0.9767239184860677,0.9999662504619572,0,0,0.4050362782757149,0.0095391097361487,GSTM2;TERT;TGFBR1
KEGG_2021_Human,Colorectal cancer,1/86,0.9768439191390592,0.9999662504619572,0,0,0.2625706020112963,0.0061516077616742,TGFBR1
KEGG_2021_Human,Insulin secretion,1/86,0.9768439191390592,0.9999662504619572,0,0,0.2625706020112963,0.0061516077616742,CAMK2A
KEGG_2021_Human,Influenza A,3/172,0.979658250427234,0.9999662504619572,0,0,0.3953662805233769,0.0081253670262606,NXF1;TMPRSS2;CPSF4L
KEGG_2021_Human,PD-L1 expression and PD-1 checkpoint pathway in cancer,1/89,0.979700131595314,0.9999662504619572,0,0,0.2535794123908878,0.0052005948237185,HIF1A
KEGG_2021_Human,Lipid and atherosclerosis,4/215,0.9835911134955488,0.9999662504619572,0,0,0.4217842404531051,0.0069784216729619,SELP;CAMK2A;LDLR;SELE
KEGG_2021_Human,Ubiquitin mediated proteolysis,2/140,0.984247623145762,0.9999662504619572,0,0,0.3229352498428394,0.0051274897004135,CBLB;UBE2J1
KEGG_2021_Human,Fc gamma R-mediated phagocytosis,1/97,0.9857111529452416,0.9999662504619572,0,0,0.2323502146760343,0.0033439646859148,SYK
KEGG_2021_Human,Phosphatidylinositol signaling system,1/97,0.9857111529452416,0.9999662504619572,0,0,0.2323502146760343,0.0033439646859148,SYNJ2
KEGG_2021_Human,Spinocerebellar ataxia,2/143,0.985938372026996,0.9999662504619572,0,0,0.3160144005720319,0.0044752156066872,SP1;ATG14
KEGG_2021_Human,Glycerophospholipid metabolism,1/98,0.9863248711551668,0.9999662504619572,0,0,0.2299427798836283,0.003166195892871,PLA2G2C
KEGG_2021_Human,Human cytomegalovirus infection,4/225,0.988064545929674,0.9999662504619572,0,0,0.4024862950694153,0.0048327549670598,CXCL12;IL10RB;SP1;GNG12
KEGG_2021_Human,Spliceosome,2/150,0.9892253864649588,0.9999662504619572,0,0,0.3009568771585184,0.0032602899364374,SNRNP27;SF3B1
KEGG_2021_Human,Chemokine signaling pathway,3/192,0.9897549722229236,0.9999662504619572,0,0,0.3531559728742827,0.0036367540485261,CXCL12;GNG12;PIK3R6
KEGG_2021_Human,Thermogenesis,4/232,0.9904763195264104,0.9999662504619572,0,0,0.3899849506256829,0.0037318910704884,COX19;NDUFC2-KCTD14;PRKG1;FGFR1
KEGG_2021_Human,Pathogenic Escherichia coli infection,3/197,0.9913942203543584,0.9999662504619572,0,0,0.3439632641208073,0.002972882469825,TUBA1C;CLDN4;F2
KEGG_2021_Human,MicroRNAs in cancer,6/310,0.992274048034434,0.9999662504619572,0,0,0.4379998140226892,0.003397105424191,TNXB;IRS1;CCNG1;SIRT1;CD44;CDC25A
KEGG_2021_Human,Epstein-Barr virus infection,3/202,0.9927787975191876,0.9999662504619572,0,0,0.3352325005308231,0.0024295645491768,CCNA2;SYK;CD44
KEGG_2021_Human,Hepatitis B,2/162,0.9932009670295652,0.9999662504619572,0,0,0.2782092614302462,0.0018980136062507,CCNA2;TGFBR1
KEGG_2021_Human,Shigellosis,4/246,0.9939766022898956,0.9999662504619572,0,0,0.3671519165590312,0.0022181892583568,C3;ATG14;CD44;HK2
KEGG_2021_Human,Parkinson disease,4/249,0.9945457706109936,0.9999662504619572,0,0,0.3625986234681886,0.0019831091643598,TUBA1C;CAMK2A;NDUFC2-KCTD14;UBE2J1
KEGG_2021_Human,Salmonella infection,4/249,0.9945457706109936,0.9999662504619572,0,0,0.3625986234681886,0.0019831091643598,TUBA1C;SNX18;RRAS;M6PR
KEGG_2021_Human,Human immunodeficiency virus 1 infection,3/212,0.9949306360037232,0.9999662504619572,0,0,0.3190241930049194,0.0016213628782993,PAK6;GNG12;AP1M2
KEGG_2021_Human,NOD-like receptor signaling pathway,2/181,0.9967492273828304,0.9999662504619572,0,0,0.2484297942850406,0.0008089042679760653,NLRP1;ANTXR2
KEGG_2021_Human,Huntington disease,5/306,0.9971004493513144,0.9999662504619572,0,0,0.3682626538987688,0.0010693472805896,TUBA1C;SP1;GPX3;ATG14;NDUFC2-KCTD14
KEGG_2021_Human,Alcoholism,2/186,0.9973271828111608,0.9999662504619572,0,0,0.2416152709108517,0.000646658034020708,GNG12;SLC29A3
KEGG_2021_Human,RNA transport,2/186,0.9973271828111608,0.9999662504619572,0,0,0.2416152709108517,0.000646658034020708,NXF1;EIF3E
KEGG_2021_Human,Estrogen signaling pathway,1/137,0.9975347376493436,0.9999662504619572,0,0,0.1636675161868026,0.0004039815307628655,SP1
KEGG_2021_Human,Prion disease,4/273,0.9975653398558618,0.9999662504619572,0,0,0.3298284546062144,0.0008039993230173333,TUBA1C;C5;C6;NDUFC2-KCTD14
KEGG_2021_Human,Measles,1/139,0.9977421685305258,0.9999662504619572,0,0,0.1612785527610901,0.0003645514947365018,CBLB
KEGG_2021_Human,Amyotrophic lateral sclerosis,6/364,0.9985044719005568,0.9999662504619572,0,0,0.3708668101150877,0.0005550568907974521,TUBA1C;NXF1;GPX3;VAPB;ATG14;NDUFC2-KCTD14
KEGG_2021_Human,Necroptosis,1/159,0.9990622338616236,0.9999662504619572,0,0,0.1407153232739454,0.0001320199769284287,CAMK2A
KEGG_2021_Human,Herpes simplex virus 1 infection,9/498,0.9993187412323794,0.9999662504619572,0,0,0.4058652047165296,0.000276593455744869,C3;NXF1;C5;ZNF582;ZNF492;TNFSF14;SYK;ZNF528;ZNF300
KEGG_2021_Human,Pathways of neurodegeneration,7/475,0.9998527632131374,0.9999662504619572,0,0,0.3294302330269311,4.8507820161700776e-05,TUBA1C;GPX3;VAPB;CAMK2A;ATG14;NDUFC2-KCTD14;UBE2J1
KEGG_2021_Human,Alzheimer disease,4/369,0.9999158377515864,0.9999662504619572,0,0,0.2418427957439273,2.0354890021102423e-05,TUBA1C;IRS1;ATG14;NDUFC2-KCTD14
KEGG_2021_Human,Olfactory transduction,5/440,0.9999662504619572,0.9999662504619572,0,0,0.2530087897227857,8.539073869650872e-06,OR1L8;CAMK2A;OR4D9;OR13A1;PRKG1
